Literature DB >> 18990748

International Lung Cancer Consortium: pooled analysis of sequence variants in DNA repair and cell cycle pathways.

Rayjean J Hung1, David C Christiani, Angela Risch, Odilia Popanda, Aage Haugen, Shan Zienolddiny, Simone Benhamou, Christine Bouchardy, Qing Lan, Margaret R Spitz, H-Erich Wichmann, Loic LeMarchand, Paolo Vineis, Giuseppe Matullo, Chikako Kiyohara, Zuo-Feng Zhang, Benhnaz Pezeshki, Curtis Harris, Leah Mechanic, Adeline Seow, Daniel P K Ng, Neonila Szeszenia-Dabrowska, David Zaridze, Jolanta Lissowska, Peter Rudnai, Eleonora Fabianova, Dana Mates, Lenka Foretova, Vladimir Janout, Vladimir Bencko, Neil Caporaso, Chu Chen, Eric J Duell, Gary Goodman, John K Field, Richard S Houlston, Yun-Chul Hong, Maria Teresa Landi, Philip Lazarus, Joshua Muscat, John McLaughlin, Ann G Schwartz, Hongbing Shen, Isabelle Stucker, Kazuo Tajima, Keitaro Matsuo, Michael Thun, Ping Yang, John Wiencke, Angeline S Andrew, Stephanie Monnier, Paolo Boffetta, Paul Brennan.   

Abstract

BACKGROUND: The International Lung Cancer Consortium was established in 2004. To clarify the role of DNA repair genes in lung cancer susceptibility, we conducted a pooled analysis of genetic variants in DNA repair pathways, whose associations have been investigated by at least 3 individual studies.
METHODS: Data from 14 studies were pooled for 18 sequence variants in 12 DNA repair genes, including APEX1, OGG1, XRCC1, XRCC2, XRCC3, ERCC1, XPD, XPF, XPG, XPA, MGMT, and TP53. The total number of subjects included in the analysis for each variant ranged from 2,073 to 13,955 subjects.
RESULTS: Four of the variants were found to be weakly associated with lung cancer risk with borderline significance: these were XRCC3 T241M [heterozygote odds ratio (OR), 0.89; 95% confidence interval (95% CI), 0.79-0.99 and homozygote OR, 0.84; 95% CI, 0.71-1.00] based on 3,467 cases and 5,021 controls from 8 studies, XPD K751Q (heterozygote OR, 0.99; 95% CI, 0.89-1.10 and homozygote OR, 1.19; 95% CI, 1.02-1.39) based on 6,463 cases and 6,603 controls from 9 studies, and TP53 R72P (heterozygote OR, 1.14; 95% CI, 1.00-1.29 and homozygote OR, 1.20; 95% CI, 1.02-1.42) based on 3,610 cases and 5,293 controls from 6 studies. OGG1 S326C homozygote was suggested to be associated with lung cancer risk in Caucasians (homozygote OR, 1.34; 95% CI, 1.01-1.79) based on 2,569 cases and 4,178 controls from 4 studies but not in Asians. The other 14 variants did not exhibit main effects on lung cancer risk. DISCUSSION: In addition to data pooling, future priorities of International Lung Cancer Consortium include coordinated genotyping and multistage validation for ongoing genome-wide association studies.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18990748      PMCID: PMC2756735          DOI: 10.1158/1055-9965.EPI-08-0411

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  34 in total

1.  Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium.

Authors:  Christopher S Carlson; Michael A Eberle; Mark J Rieder; Qian Yi; Leonid Kruglyak; Deborah A Nickerson
Journal:  Am J Hum Genet       Date:  2003-12-15       Impact factor: 11.025

Review 2.  Cell-cycle checkpoints and cancer.

Authors:  Michael B Kastan; Jiri Bartek
Journal:  Nature       Date:  2004-11-18       Impact factor: 49.962

3.  Sequence variants in cell cycle control pathway, X-ray exposure, and lung cancer risk: a multicenter case-control study in Central Europe.

Authors:  Rayjean J Hung; Paolo Boffetta; Federico Canzian; Norman Moullan; Neonila Szeszenia-Dabrowska; David Zaridze; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Lenka Foretova; Vladimir Janout; Vladimir Bencko; Amelie Chabrier; Stefano Landi; Federica Gemignani; Janet Hall; Paul Brennan
Journal:  Cancer Res       Date:  2006-08-15       Impact factor: 12.701

4.  Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1.

Authors:  Christopher I Amos; Xifeng Wu; Peter Broderick; Ivan P Gorlov; Jian Gu; Timothy Eisen; Qiong Dong; Qing Zhang; Xiangjun Gu; Jayaram Vijayakrishnan; Kate Sullivan; Athena Matakidou; Yufei Wang; Gordon Mills; Kimberly Doheny; Ya-Yu Tsai; Wei Vivien Chen; Sanjay Shete; Margaret R Spitz; Richard S Houlston
Journal:  Nat Genet       Date:  2008-04-02       Impact factor: 38.330

5.  Two polymorphic variants of wild-type p53 differ biochemically and biologically.

Authors:  M Thomas; A Kalita; S Labrecque; D Pim; L Banks; G Matlashewski
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

6.  Meta-analysis in clinical trials.

Authors:  R DerSimonian; N Laird
Journal:  Control Clin Trials       Date:  1986-09

7.  p53 Genotypes and Haplotypes Associated With Lung Cancer Susceptibility and Ethnicity.

Authors:  Xifeng Wu; Hua Zhao; Christopher I Amos; Sanjay Shete; Nimisha Makan; Waun K Hong; Fred F Kadlubar; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2002-05-01       Impact factor: 13.506

Review 8.  XRCC3 and XPD/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review.

Authors:  Maurizio Manuguerra; Federica Saletta; Margaret R Karagas; Marianne Berwick; Fabrizio Veglia; Paolo Vineis; Giuseppe Matullo
Journal:  Am J Epidemiol       Date:  2006-05-17       Impact factor: 4.897

9.  The codon 72 polymorphic variants of p53 have markedly different apoptotic potential.

Authors:  Patrick Dumont; J I-Ju Leu; Anthony C Della Pietra; Donna L George; Maureen Murphy
Journal:  Nat Genet       Date:  2003-02-03       Impact factor: 38.330

10.  Role of RAD51C and XRCC3 in genetic recombination and DNA repair.

Authors:  Yilun Liu; Madalena Tarsounas; Paul O'regan; Stephen C West
Journal:  J Biol Chem       Date:  2006-11-17       Impact factor: 5.157

View more
  56 in total

1.  Germ line variation in nucleotide excision repair genes and lung cancer risk in smokers.

Authors:  Lori C Sakoda; Melissa M Loomis; Jennifer A Doherty; Liberto Julianto; Matt J Barnett; Marian L Neuhouser; Mark D Thornquist; Noel S Weiss; Gary E Goodman; Chu Chen
Journal:  Int J Mol Epidemiol Genet       Date:  2012-02-05

2.  Replication of lung cancer susceptibility loci at chromosomes 15q25, 5p15, and 6p21: a pooled analysis from the International Lung Cancer Consortium.

Authors:  Therese Truong; Rayjean J Hung; Christopher I Amos; Xifeng Wu; Heike Bickeböller; Albert Rosenberger; Wiebke Sauter; Thomas Illig; H-Erich Wichmann; Angela Risch; Hendrik Dienemann; Rudolph Kaaks; Ping Yang; Ruoxiang Jiang; John K Wiencke; Margaret Wrensch; Helen Hansen; Karl T Kelsey; Keitaro Matsuo; Kazuo Tajima; Ann G Schwartz; Angie Wenzlaff; Adeline Seow; Chen Ying; Andrea Staratschek-Jox; Peter Nürnberg; Erich Stoelben; Jürgen Wolf; Philip Lazarus; Joshua E Muscat; Carla J Gallagher; Shanbeh Zienolddiny; Aage Haugen; Henricus F M van der Heijden; Lambertus A Kiemeney; Dolores Isla; Jose Ignacio Mayordomo; Thorunn Rafnar; Kari Stefansson; Zuo-Feng Zhang; Shen-Chih Chang; Jin Hee Kim; Yun-Chul Hong; Eric J Duell; Angeline S Andrew; Flavio Lejbkowicz; Gad Rennert; Heiko Müller; Hermann Brenner; Loïc Le Marchand; Simone Benhamou; Christine Bouchardy; M Dawn Teare; Xiaoyan Xue; John McLaughlin; Geoffrey Liu; James D McKay; Paul Brennan; Margaret R Spitz
Journal:  J Natl Cancer Inst       Date:  2010-06-14       Impact factor: 13.506

3.  Identification of lung cancer histology-specific variants applying Bayesian framework variant prioritization approaches within the TRICL and ILCCO consortia.

Authors:  Darren R Brenner; Christopher I Amos; Yonathan Brhane; Maria N Timofeeva; Neil Caporaso; Yufei Wang; David C Christiani; Heike Bickeböller; Ping Yang; Demetrius Albanes; Victoria L Stevens; Susan Gapstur; James McKay; Paolo Boffetta; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Dana Mates; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Hans E Krokan; Frank Skorpen; Maiken E Gabrielsen; Lars Vatten; Inger Njølstad; Chu Chen; Gary Goodman; Mark Lathrop; Tõnu Vooder; Kristjan Välk; Mari Nelis; Andres Metspalu; Peter Broderick; Timothy Eisen; Xifeng Wu; Di Zhang; Wei Chen; Margaret R Spitz; Yongyue Wei; Li Su; Dong Xie; Jun She; Keitaro Matsuo; Fumihiko Matsuda; Hidemi Ito; Angela Risch; Joachim Heinrich; Albert Rosenberger; Thomas Muley; Hendrik Dienemann; John K Field; Olaide Raji; Ying Chen; John Gosney; Triantafillos Liloglou; Michael P A Davies; Michael Marcus; John McLaughlin; Irene Orlow; Younghun Han; Yafang Li; Xuchen Zong; Mattias Johansson; Geoffrey Liu; Shelley S Tworoger; Loic Le Marchand; Brian E Henderson; Lynne R Wilkens; Juncheng Dai; Hongbing Shen; Richard S Houlston; Maria T Landi; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2015-09-10       Impact factor: 4.944

4.  Note of clarification of data in the paper titled X-ray repair cross-complementing group 1 codon 399 polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Wenlong Zhai; Ruo Feng; Haiyu Wang; Yadong Wang
Journal:  Tumour Biol       Date:  2015-04-03

5.  Carcinogenesis-related changes in iron metabolism in chronic obstructive pulmonary disease subjects with lung cancer.

Authors:  Kamil Brzóska; Teresa Bartłomiejczyk; Barbara Sochanowicz; Magdalena Cymerman; Jacek Grudny; Jacek Kołakowski; Marcin Kruszewski; Paweł Śliwiński; Kazimierz Roszkowski-Śliż; Lucyna Kapka-Skrzypczak
Journal:  Oncol Lett       Date:  2018-09-19       Impact factor: 2.967

6.  International Lung Cancer Consortium: coordinated association study of 10 potential lung cancer susceptibility variants.

Authors:  Therese Truong; Wiebke Sauter; James D McKay; H Dean Hosgood; Carla Gallagher; Christopher I Amos; Margaret Spitz; Joshua Muscat; Philip Lazarus; Thomas Illig; H Erich Wichmann; Heike Bickeböller; Angela Risch; Hendrik Dienemann; Zuo-Feng Zhang; Behnaz Pezeshki Naeim; Ping Yang; Shanbeh Zienolddiny; Aage Haugen; Loïc Le Marchand; Yun-Chul Hong; Jin Hee Kim; Eric J Duell; Angeline S Andrew; Chikako Kiyohara; Hongbing Shen; Keitaro Matsuo; Takeshi Suzuki; Adeline Seow; Daniel P K Ng; Qing Lan; David Zaridze; Neonilia Szeszenia-Dabrowska; Jolanta Lissowska; Peter Rudnai; Eleonora Fabianova; Vali Constantinescu; Vladimir Bencko; Lenka Foretova; Vladimir Janout; Neil E Caporaso; Demetrius Albanes; Michael Thun; Maria Teresa Landi; Joanna Trubicka; Marcin Lener; Jan Lubinski; Ying Wang; Amélie Chabrier; Paolo Boffetta; Paul Brennan; Rayjean J Hung
Journal:  Carcinogenesis       Date:  2010-01-27       Impact factor: 4.944

7.  Lung cancer in never smokers: a call to action.

Authors:  Charles M Rudin; Erika Avila-Tang; Jonathan M Samet
Journal:  Clin Cancer Res       Date:  2009-09-15       Impact factor: 12.531

8.  XPA A23G polymorphism and lung cancer risk: a meta-analysis.

Authors:  Ji-Hong Zou; Li An; Shi Chen; Li-Qun Ren
Journal:  Mol Biol Rep       Date:  2011-05-25       Impact factor: 2.316

9.  Lack of association between XRCC3 rs861539 (C > T) polymorphism and lung cancer risks: an update meta-analysis.

Authors:  Chun-Lei Shi; Rong Li; Li-Wen Xiong; Ai-Qin Gu; Bao-Hui Han; Wei Gu
Journal:  Tumour Biol       Date:  2013-03-26

10.  Analysis of SNPs and haplotypes in vitamin D pathway genes and renal cancer risk.

Authors:  Sara Karami; Paul Brennan; Philip S Rosenberg; Marie Navratilova; Dana Mates; David Zaridze; Vladimir Janout; Helena Kollarova; Vladimir Bencko; Vsevolod Matveev; Neonila Szeszenia-Dabrowska; Ivana Holcatova; Meredith Yeager; Stephen Chanock; Idan Menashe; Nathaniel Rothman; Wong-Ho Chow; Paolo Boffetta; Lee E Moore
Journal:  PLoS One       Date:  2009-09-15       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.